China’s State FDA Sees Big Challenges In Food And Drug Administration
This article was originally published in PharmAsia News
After last year's governmental reform, China's State FDA is now responsible for supervising five kinds of public health-related products, namely, consumer food, health care products, cosmetics, drugs and medical devices. It is facing big challenges in food and drug safety supervision. Key issues include the problem of completely overhauling and standardizing the fragmented food and drug industry beleaguered with diverse small segments, varied levels of industrialization and focus. In addition, manufacturing of counterfeit drugs and sale of such medicines online to remote areas put more pressure on monitoring. However, SFDA will step up efforts to improve legislation, raise standards and tighten supervision, with special focus on investigating fake drugs posing as medicine, illegitimate additives in patented TCM and illegal drug advertisements. (Click here for more - Chinese Language)
You may also be interested in...
EU Scientific Committee Affirms Safety Of Anti-Dandruff Zinc Pyrithione Under Threat Of Cosmetic Ban
The Scientific Committee for Consumer Safety upholds that zinc pyrithione is safe for use in rinse-off anti-dandruff hair products at levels up to 1%. In recent years, the cosmetics industry has pushed for a 2% ceiling on ZPT content in that capacity – with considerable inroads made. Where that proposal now stands vis-à-vis the ingredient’s pending CMR 1B classification and shifting political sands is uncertain.
New potential topical therapy in dermatitis space set to move towards Japan approval submission based on positive new results.
Company’s promise to be more forthright, along with quality culture and policy upgrades, may have helped sway agency.